Drug Type Recombinant protein |
Synonyms Hu sCD146 (Aix-Marseille Universite/SATT Paca Corse), recombinant hum |
Target |
Mechanism FN1 stimulants(Fibronectin stimulants), ITGB4 agonists(integrin subunit beta 4 agonists), Muc18 stimulants(Melanoma cell adhesion molecule stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Perioperative ischaemia | Preclinical | FR | - | |
Perioperative ischaemia | Discovery | FR | - | |
Perioperative ischaemia | Discovery | FR | - | |
Wounds and Injuries | Discovery | FR | - | |
Wounds and Injuries | Discovery | FR | - | |
Wounds and Injuries | Discovery | FR | - |